143 related articles for article (PubMed ID: 8676072)
1. Binding and cooperative interactions between two B cell-specific transcriptional coactivators.
Fontes JD; Jabrane-Ferrat N; Toth CR; Peterlin BM
J Exp Med; 1996 Jun; 183(6):2517-21. PubMed ID: 8676072
[TBL] [Abstract][Full Text] [Related]
2. The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.
Brown JA; Rogers EM; Boss JM
Nucleic Acids Res; 1998 Sep; 26(18):4128-36. PubMed ID: 9722631
[TBL] [Abstract][Full Text] [Related]
3. Bob1 (OCA-B/OBF-1) differential transactivation of the B cell-specific B29 (Ig beta) and mb-1 (Ig alpha) promoters.
Malone CS; Wall R
J Immunol; 2002 Apr; 168(7):3369-75. PubMed ID: 11907094
[TBL] [Abstract][Full Text] [Related]
4. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.
Gstaiger M; Georgiev O; van Leeuwen H; van der Vliet P; Schaffner W
EMBO J; 1996 Jun; 15(11):2781-90. PubMed ID: 8654375
[TBL] [Abstract][Full Text] [Related]
5. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.
Masternak K; Muhlethaler-Mottet A; Villard J; Zufferey M; Steimle V; Reith W
Genes Dev; 2000 May; 14(9):1156-66. PubMed ID: 10809673
[TBL] [Abstract][Full Text] [Related]
6. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
Masternak K; Reith W
EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
[TBL] [Abstract][Full Text] [Related]
7. Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III.
Holling TM; van der Stoep N; Quinten E; van den Elsen PJ
J Immunol; 2002 Jan; 168(2):763-70. PubMed ID: 11777970
[TBL] [Abstract][Full Text] [Related]
8. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5.
Scholl T; Mahanta SK; Strominger JL
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6330-4. PubMed ID: 9177217
[TBL] [Abstract][Full Text] [Related]
9. A novel element and a TEF-2-like element activate the major histocompatibility complex class II transactivator in B-lymphocytes.
Ghosh N; Piskurich JF; Wright G; Hassani K; Ting JP; Wright KL
J Biol Chem; 1999 Nov; 274(45):32342-50. PubMed ID: 10542275
[TBL] [Abstract][Full Text] [Related]
10. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.
Wright KL; Ting JP
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7601-5. PubMed ID: 1502171
[TBL] [Abstract][Full Text] [Related]
11. Cis-element dependence and occupancy of the human invariant chain promoter in CIITA-dependent and -independent transcription.
Tai AK; Zhou G; Chau K; Ono SJ
Mol Immunol; 1999 May; 36(7):447-60. PubMed ID: 10449097
[TBL] [Abstract][Full Text] [Related]
12. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.
Piskurich JF; Gilbert CA; Ashley BD; Zhao M; Chen H; Wu J; Bolick SC; Wright KL
Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283
[TBL] [Abstract][Full Text] [Related]
13. CREB and phospho-CREB interact with RFX5 and CIITA to regulate MHC class II genes.
Lochamy J; Rogers EM; Boss JM
Mol Immunol; 2007 Feb; 44(5):837-47. PubMed ID: 16730065
[TBL] [Abstract][Full Text] [Related]
14. The S box of major histocompatibility complex class II promoters is a key determinant for recruitment of the transcriptional co-activator CIITA.
Muhlethaler-Mottet A; Krawczyk M; Masternak K; Spilianakis C; Kretsovali A; Papamatheakis J; Reith W
J Biol Chem; 2004 Sep; 279(39):40529-35. PubMed ID: 15271997
[TBL] [Abstract][Full Text] [Related]
15. A B-cell coactivator of octamer-binding transcription factors.
Gstaiger M; Knoepfel L; Georgiev O; Schaffner W; Hovens CM
Nature; 1995 Jan; 373(6512):360-2. PubMed ID: 7779176
[TBL] [Abstract][Full Text] [Related]
16. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.
Chen H; Gilbert CA; Hudson JA; Bolick SC; Wright KL; Piskurich JF
Mol Immunol; 2007 Feb; 44(6):1461-70. PubMed ID: 16765445
[TBL] [Abstract][Full Text] [Related]
17. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA).
Riley JL; Westerheide SD; Price JA; Brown JA; Boss JM
Immunity; 1995 May; 2(5):533-43. PubMed ID: 7749984
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma inducibility of class II transactivator is specifically lacking in human tumour lines: relevance to retinoblastoma protein rescue of IFN-gamma inducibility of the HLA class II genes.
Lu Y; Tschickardt ME; Schmidt BJ; Blanck G
Immunol Cell Biol; 1997 Aug; 75(4):325-32. PubMed ID: 9315472
[TBL] [Abstract][Full Text] [Related]
19. Self-association of CIITA and its transactivation potential.
Sisk TJ; Roys S; Chang CH
Mol Cell Biol; 2001 Aug; 21(15):4919-28. PubMed ID: 11438649
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
Dong Y; Rohn WM; Benveniste EN
J Immunol; 1999 Apr; 162(8):4731-9. PubMed ID: 10202014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
